NGL Fine Chem
1,485.50
+16.30(+1.11%)
Market Cap₹917.70 Cr
PE Ratio43.66
IndustryHealthcare
Company Performance:
1D+1.11%
1M+0.47%
6M+32.63%
1Y-29.06%
5Y-20.52%
View Company Insightsright
Latest news about NGL Fine Chem
NGL Fine-Chem Invests Rs. 119.83 Crore in Plant Expansion During Q1 Aug 07, 2025
NGL Fine Chem, a leader in the animal health sector, has invested Rs. 119.83 crore in Q1 for the expansion of its S-18 plant. The CAPEX completion is now expected in Q4 due to executional delays. Despite industry challenges, the company reported 14.80% YoY revenue growth to Rs. 104.19 crore in Q1. EBITDA increased by 17.36% to Rs. 10.97 crore, with a margin improvement of 23 basis points. The company remains focused on diversification into regulated markets for better profitability.
NGL Fine-Chem Reports Robust Q1FY26 Performance Amid Industry Headwinds Aug 07, 2025
NGL Fine-Chem Reports Strong Q1 FY2026 Results with 18.6% Revenue Growth Aug 01, 2025
NGL Fine-Chem Reports Sharp Decline in Q4 Profits, Announces Dividend May 22, 2025
NGL Fine Chem Achieves Milestone with Partial Expansion at Plant S-18 Mar 26, 2025
More news about NGL Fine Chem
26Feb 25
NGL Fine-Chem Settles Disclosure Violation Case with SEBI for ₹92.21 Lakh
NGL Fine-Chem Limited and its promoters have settled with SEBI for ₹92.21 lakh regarding shareholding disclosure violations from 2002 to 2019. The company incorrectly classified PCI Ferrmone Chemicals as 'public/non-promoter' instead of 'promoter group' for 31 quarters. Promoters failed to disclose PCI Ferrmone's shareholding in their SAST disclosures. The settlement, reached without admission of guilt, includes payments from the company (₹54.42 lakh), PCI Ferrmone, and two promoters (₹12.60 lakh each). NGL Fine-Chem states the settlement won't impact its financial or operational activities beyond the payment.
NGL Fine Chem
1,485.50
+16.30
(+1.11%)
1 Year Returns:-29.06%
Industry Peers
Sun Pharmaceutical
1,691.40
(+0.33%)
Divis Laboratories
6,656.50
(-3.30%)
Cipla
1,505.70
(+0.28%)
Torrent Pharmaceuticals
3,580.00
(+0.75%)
Dr Reddys Laboratories
1,205.40
(+0.02%)
Zydus Life Science
944.10
(+0.79%)
Mankind Pharma
2,261.80
(-2.05%)
Lupin
1,971.80
(+0.83%)
Alkem Laboratories
5,668.50
(+0.44%)
Aurobindo Pharma
1,123.80
(-1.47%)